User contributions
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 15:44, 14 February 2015 (diff | hist) . . (0) . . AB-FUBINACA (current)
- 15:44, 14 February 2015 (diff | hist) . . (-19) . . AB-FUBINACA (→See also)
- 15:42, 14 February 2015 (diff | hist) . . (+719) . . N AB-FUBINACA (Created page with "AB-FUBINACA is a drug that acts as a potent agonist for the cannabinoid receptors, with Ki values of 0.9nM at CB1 and 23.2nM at CB2. It was originally developed by...")
- 15:39, 14 February 2015 (diff | hist) . . (+314) . . N NESS-040C5 (Created page with "NESS-040C5 is a potent cannabinoid agonist which was developed for the treatment of glaucoma. It has reasonable selectivity for the CB2 receptor subtype, having a CB2...") (current)
- 15:36, 14 February 2015 (diff | hist) . . (+695) . . N SR-144,528 (Created page with "SR144528 is a drug that acts as a potent and highly selective CB2 receptor inverse agonist, with a Ki of 0.6nM at CB2 and 400nM at the related CB1 receptor. It is used...") (current)
- 15:32, 14 February 2015 (diff | hist) . . (+1,244) . . N AM-1241 (Created page with "AM-1241 (1-(methylpiperidin-2-ylmethyl)-3-(2-iodo-5-nitrobenzoyl)indole) is a chemical from the aminoalkylindole family that acts as a potent and selective agonist for the can...") (current)
- 15:28, 14 February 2015 (diff | hist) . . (+538) . . N O-1812 (Created page with "O-1812 is an eicosanoid derivative related to anandamide that acts as a potent and highly selective agonist for the cannabinoid receptor CB1, with a Ki of 3.4nM at CB1 and...") (current)
- 15:26, 14 February 2015 (diff | hist) . . (0) . . AM-2389 (current)
- 15:26, 14 February 2015 (diff | hist) . . (0) . . AM-2389
- 15:25, 14 February 2015 (diff | hist) . . (+928) . . N AM-2389 (Created page with "AM-2389 is a classical cannabinoid derivative which acts as a potent and reasonably selective agonist for the CB1 receptor, with a Ki of 0.16 nM, and 26x selectivity over...")
- 07:03, 14 February 2015 (diff | hist) . . (+305) . . N AM-906 (Created page with "AM-906 is an analgesic drug which is a cannabinoid agonist with a conformationally restricted side chain. It is a potent and selective agonist for the CB1 cannabinoid...") (current)
- 07:01, 14 February 2015 (diff | hist) . . (+1,242) . . N AM-1235 (Created page with "AM-1235 (1-(5-fluoropentyl)-3-(naphthalen-1-oyl)-6-nitroindole) is a drug that acts as a potent and reasonably selective agonist for the cannabinoid receptor CB1. == Pha...") (current)
- 06:57, 14 February 2015 (diff | hist) . . (+627) . . N AM-2233 (Created page with "AM-2233 is a drug that acts as a highly potent full agonist for the cannabinoid receptors, with a Ki of 1.8nM at CB1 and 2.2nM at CB2 as the active (R) enantiomer. It...")
- 06:54, 14 February 2015 (diff | hist) . . (+777) . . N RCS-8 (Created page with "RCS-8, or 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole, is a synthetic cannabinoid also known as SR-18 or BTM-8 that has been found as an ingredient of "herbal" syn...")
- 06:52, 14 February 2015 (diff | hist) . . (-56) . . AB-001 (→See also) (current)
- 06:49, 14 February 2015 (diff | hist) . . (+1,133) . . N AB-001 (Created page with "AB-001 or 1-pentyl-3-(1-adamantoyl)indole is a designer drug that was found as an ingredient in synthetic cannabis smoking blends in Ireland in 2010 and Hungary and Germany in...")
- 06:46, 14 February 2015 (diff | hist) . . (+1,473) . . N XLR-11 (drug) (Created page with "XLR-11 (5"-fluoro-UR-144) is a drug that acts as a potent agonist for the cannabinoid receptors CB1 and CB2 with a Ki of 24.2nM and a EC50 of 359nM at CB1. It is a 3-(...") (current)
- 06:38, 14 February 2015 (diff | hist) . . (-4) . . AM-1248 (current)
- 06:38, 14 February 2015 (diff | hist) . . (+807) . . N AM-1248 (Created page with "AM-1248 is a drug that acts as a moderately potent agonist for both the cannabinoid receptors CB1 and CB2, but with some dispute between sources over its exact potency...")
- 06:34, 14 February 2015 (diff | hist) . . (+187) . . UR-144 (current)
- 06:32, 14 February 2015 (diff | hist) . . (+1,939) . . N UR-144 (Created page with "UR-144 (TMCP-018, KM-X1, MN-001, YX-17) is a drug invented by Abbott Laboratories, that acts as a selective full agonist of the peripheral cannabinoid receptor CB2, but wi...")
- 06:28, 14 February 2015 (diff | hist) . . (+996) . . N A-834,735 (Created page with "A-834,735 is a drug developed by Abbott Laboratories that acts as a potent cannabinoid receptor full agonist at both the CB1 and CB2 receptors, with a Ki of 12nM at CB...") (current)
- 06:25, 14 February 2015 (diff | hist) . . (+1,304) . . N AM-1220 (Created page with "AM-1220 is a drug that acts as a potent and moderately selective agonist for the cannabinoid receptor CB1, with around 19x selectivity for CB1 over the related CB2 rec...") (current)
- 06:22, 14 February 2015 (diff | hist) . . (+766) . . N AM-1221 (Created page with "AM-1221 is a drug that acts as a potent and selective agonist for the cannabinoid receptor CB2, with a Ki of 0.28nM at CB2 and 52.3nM at the CB1 receptor, giving it ar...") (current)
- 06:19, 14 February 2015 (diff | hist) . . (+18) . . N WIN 55,225 (Created page with "See as JWH-200") (current)
- 06:18, 14 February 2015 (diff | hist) . . (+371) . . N WIN 56,098 (Created page with "WIN 56,098 is a chemical that is considered to be an aminoalkylindole derivative. It is a tricyclic aryl derivative that acts as a competitive antagonist at the CB2 cannab...") (current)
- 06:16, 14 February 2015 (diff | hist) . . (+22) . . N WIN 48,098 (Created page with "See as Pravadoline") (current)
- 06:15, 14 February 2015 (diff | hist) . . (+4) . . Pravadoline (current)
- 06:14, 14 February 2015 (diff | hist) . . (-12) . . Pravadoline (→Animal studies)
- 06:13, 14 February 2015 (diff | hist) . . (+2,311) . . N Pravadoline (Created page with "Pravadoline (WIN 48,098) is an antiinflammatory and analgesic drug with an IC50 of 4.9 µM and a Ki of 2511nM at CB1, related in structure to non-steroidal antinflammtory drug...")
- 06:09, 14 February 2015 (diff | hist) . . (+925) . . N JWH-200 (Created page with "JWH-200 (WIN 55,225) is an analgesic chemical from the aminoalkylindole family that acts as a cannabinoid receptor agonist. Its binding affinity at the CB1 receptor is 42n...")
- 06:06, 14 February 2015 (diff | hist) . . (+1) . . WIN 55,212-2 (→See also) (current)
- 06:05, 14 February 2015 (diff | hist) . . (+1,373) . . N WIN 55,212-2 (Created page with "WIN 55,212-2 is a chemical described as an aminoalkylindole derivative, which produces effects similar to those of cannabinoids such as tetrahydrocannabinol (THC) but...")
- 06:02, 14 February 2015 (diff | hist) . . (+198) . . N WIN 54,461 (Created page with "WIN 54,461 (6-Bromopravadoline) is a drug that acts as a potent and selective inverse agonist for the cannabinoid receptor CB2. == See also == AM-630 (6-Iodopravado...") (current)
- 05:59, 14 February 2015 (diff | hist) . . (+770) . . N AM-630 (Created page with "AM-630 (6-Iodopravadoline) is a drug that acts as a potent and selective inverse agonist for the cannabinoid receptor CB2, with a Ki of 32.1nM at CB2 and 165x selectivity...") (current)
- 05:57, 14 February 2015 (diff | hist) . . (+856) . . N RCS-4 (Created page with "RCS-4, or 1-pentyl-3-(4-methoxybenzoyl)indole, is a synthetic cannabinoid drug sold under the names SR-19, BTM-4, or Eric-4 (later shortened to E-4), but originally, OBT-199....") (current)
- 05:53, 14 February 2015 (diff | hist) . . (0) . . JWH-018 (→Legal status) (current)
- 05:52, 14 February 2015 (diff | hist) . . (-74) . . JWH-018 (→Legal status)
- 05:50, 14 February 2015 (diff | hist) . . (+8,816) . . N JWH-018 (Created page with "JWH-018 (1-pentyl-3-(1-naphthoyl)indole) or AM-678 is an analgesic chemical from the naphthoylindole family that acts as a full agonist at both the CB1 and CB2 canna...")
- 05:29, 14 February 2015 (diff | hist) . . (+2,410) . . N HU-210 (Created page with "HU-210 is a synthetic cannabinoid that was first synthesized in 1988 from (1R,5S)-myrtenol by a group led by Professor Raphael Mechoulam at the Hebrew University. HU-210 is 10...") (current)
- 09:33, 13 February 2015 (diff | hist) . . (+541) . . N D.A.R.E. (Created page with "'''D.A.R.E.''', an acronym for '''Drug Abuse Resistance Education''', is a substance abuse prevention education program. Founded in 1983 in Los Angeles, California, it has pol...") (current)
- 09:30, 13 February 2015 (diff | hist) . . (+3,393) . . N Finnish Cannabis Association (Created page with "'''The Finnish Cannabis Association (FCA)''' (Finnish: Suomen kannabisyhdistys; Swedish: Finlands Cannabisförening, commonly referred to by the acronym SKY) is a Finnish non-...")
- 09:28, 13 February 2015 (diff | hist) . . (+6) . . Smart Approaches to Marijuana
- 09:28, 13 February 2015 (diff | hist) . . (+717) . . N Smart Approaches to Marijuana (Created page with "SAM (Smart Approaches to Marijuana) is an anti-marijuana legalization group, led by former U.S. Rep. Patrick Kennedy, Kevin Sabet, and conservative columnist David Frum. SAM...")
- 09:25, 13 February 2015 (diff | hist) . . (+2,515) . . N Rhode Island Patient Advocacy Coalition (Created page with "The Rhode Island Patient Advocacy Coalition (RIPAC) is Rhode Island's non-profit grassroots medical marijuana community. Patients, caregivers, doctors, nurses, health care pro...")
- 09:23, 13 February 2015 (diff | hist) . . (+190) . . N Republicans Against Marijuana Prohibition (Created page with "Republicans Against Marijuana Prohibition (RAMP) "works to reform marijuana laws by working within the GOP to educate and connect with lawmakers, party leadership, and grassro...") (current)
- 09:22, 13 February 2015 (diff | hist) . . (+1,868) . . N Patients Out of Time (Created page with "Patients Out of Time (POT) is a patient advocacy organization dedicated to educating public health professionals and the public about medical marijuana. Incorporated in 1995,...")
- 09:19, 13 February 2015 (diff | hist) . . (+2,954) . . N Kind For Cures (Created page with "Kind for Cures is a medicinal marijuana dispensary located in the Palms neighborhood of Los Angeles County. The dispensary inhabits a building that was previously occupied by...") (current)
- 09:17, 13 February 2015 (diff | hist) . . (+134) . . N Family Law and Cannabis Alliance (Created page with "The Family Law and Cannabis Alliance (FLCA) is an American organization formed by drug reform activists Jess Cochrane and Sara Arnold.") (current)
- 09:16, 13 February 2015 (diff | hist) . . (+4) . . Colorado Compassion Club (current)
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
